PMID- 16787992 OWN - NLM STAT- MEDLINE DCOM- 20061012 LR - 20181201 IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 91 IP - 9 DP - 2006 Sep TI - Clinical characterization of familial isolated pituitary adenomas. PG - 3316-23 AB - CONTEXT: Familial pituitary adenomas occur rarely in the absence of multiple endocrine neoplasia type 1 (MEN1) and Carney complex (CNC). OBJECTIVE: Our objective was to characterize the clinical and genealogical features of non-MEN1/CNC familial isolated pituitary adenomas (FIPA). DESIGN AND SETTING: We conducted a retrospective study of clinical and genealogical characteristics of FIPA cases and performed a comparison with a sporadic population at 22 university hospitals in Belgium, Italy, France, and The Netherlands. RESULTS: Sixty-four FIPA families including 138 affected individuals were identified [55 prolactinomas, 47 somatotropinomas, 28 nonsecreting adenomas (NS), and eight ACTH-secreting tumors]. Cases were MEN1/PRKAR1A-mutation negative. First-degree relationships predominated (75.6%) among affected individuals. A single tumor phenotype occurred in 30 families (homogeneous), and heterogeneous phenotypes occurred in 34 families. FIPA cases were younger at diagnosis than sporadic cases (P = 0.015); tumors were diagnosed earlier in the first vs. the second generation of multigenerational families. Macroadenomas were more frequent in heterogeneous vs. homogeneous FIPA families (P = 0.036). Prolactinomas from heterogeneous families were larger and had more frequent suprasellar extension (P = 0.004) than sporadic cases. Somatotropinomas occurred as isolated familial somatotropinoma cases and within heterogeneous FIPA families; isolated familial somatotropinoma cases represented 18% of FIPA cases and were younger at diagnosis than patients with sporadic somatotropinomas. Familial NS cases were younger at diagnosis (P = 0.03) and had more frequently invasive tumors (P = 0.024) than sporadic cases. CONCLUSIONS: Homogeneous and heterogeneous expression of prolactinomas, somatotropinomas, NS, and Cushing's disease can occur within families in the absence of MEN1/CNC. FIPA and sporadic cases have differing clinical characteristics. FIPA may represent a novel endocrine neoplasia classification that requires further genetic characterization. FAU - Daly, A F AU - Daly AF AD - Department of Endocrinology, Centre Hospitalier Universitaire de Liege, Domaine Universitaire du Sart Tilman, 4000 Liege, Belgium. FAU - Jaffrain-Rea, M-L AU - Jaffrain-Rea ML FAU - Ciccarelli, A AU - Ciccarelli A FAU - Valdes-Socin, H AU - Valdes-Socin H FAU - Rohmer, V AU - Rohmer V FAU - Tamburrano, G AU - Tamburrano G FAU - Borson-Chazot, C AU - Borson-Chazot C FAU - Estour, B AU - Estour B FAU - Ciccarelli, E AU - Ciccarelli E FAU - Brue, T AU - Brue T FAU - Ferolla, P AU - Ferolla P FAU - Emy, P AU - Emy P FAU - Colao, A AU - Colao A FAU - De Menis, E AU - De Menis E FAU - Lecomte, P AU - Lecomte P FAU - Penfornis, F AU - Penfornis F FAU - Delemer, B AU - Delemer B FAU - Bertherat, J AU - Bertherat J FAU - Wemeau, J L AU - Wemeau JL FAU - De Herder, W AU - De Herder W FAU - Archambeaud, F AU - Archambeaud F FAU - Stevenaert, A AU - Stevenaert A FAU - Calender, A AU - Calender A FAU - Murat, A AU - Murat A FAU - Cavagnini, F AU - Cavagnini F FAU - Beckers, A AU - Beckers A LA - eng PT - Journal Article PT - Multicenter Study PT - Research Support, Non-U.S. Gov't DEP - 20060620 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Cyclic AMP-Dependent Protein Kinase RIalpha Subunit) RN - 0 (Gonadotropins, Pituitary) RN - 0 (PRKAR1A protein, human) RN - 0 (Pituitary Hormones, Anterior) RN - 9002-60-2 (Adrenocorticotropic Hormone) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) SB - IM MH - Adenoma/*genetics/metabolism/*pathology MH - Adrenocorticotropic Hormone/metabolism MH - Adult MH - Cyclic AMP-Dependent Protein Kinase RIalpha Subunit MH - Cyclic AMP-Dependent Protein Kinases/genetics MH - Female MH - Gonadotropins, Pituitary/metabolism MH - Humans MH - Immunohistochemistry MH - Male MH - Middle Aged MH - Pedigree MH - Pituitary Hormones, Anterior/metabolism MH - Pituitary Neoplasms/*genetics/metabolism/*pathology MH - Prolactinoma/genetics/pathology MH - Retrospective Studies MH - Sequence Analysis, DNA EDAT- 2006/06/22 09:00 MHDA- 2006/10/13 09:00 CRDT- 2006/06/22 09:00 PHST- 2006/06/22 09:00 [pubmed] PHST- 2006/10/13 09:00 [medline] PHST- 2006/06/22 09:00 [entrez] AID - jc.2005-2671 [pii] AID - 10.1210/jc.2005-2671 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23. doi: 10.1210/jc.2005-2671. Epub 2006 Jun 20.